The Siemens Healthcare Diagnostics DCA HbA1c test kit, already widely used to monitor diabetes patients’ HbA1c levels, has achieved the CE mark as an aid to diagnose diabetes and identify patients at risk from developing the disease. ...
Tags: CE mark, DCA HbA1c test kit, diabetes, Siemens
Research-focused healthcare company Roche has introduced a new point-of care system for the diagnosis and management of metabolic syndrome,which is associated with a higher risk for cardiovascular and type 2 diabetes diseases. Using blood ...
Tags: Roche, Care System, Management, Metabolic Syndrome
Philosys, a contract design, development and manufacturing company, has obtained CE mark approval for its new Gmate SMART blood glucose monitor. By using the operating system of the smart phone, the patent pending technology of the Gmate ...
Tags: Philosys, Gmate SMART blood glucose monitor, Gmate SMART
Janssen Research & Development has submitted a New Drug Application (NDA) to the US FDA seeking approval for a fixed-dose therapy combining canagliflozin and immediate release metformin to treat patients with type 2 diabetes. ...
Janssen Research & Development has submitted a new drug application (NDA) to the FDA for canagliflozin to treat adult patients with type 2 diabetes. The filing is based on a global Phase III clinical development program, including nine ...
Tags: Janssen Research&Development, SGLT2, cardiovascular study
From checking blood glucose levels, to monitoring the movements of a newborn baby, Canadians are increasingly able to monitor their health across a growing variety of devices and services. What most will not know is that in the background, ...
Tags: wireless connection, CTIA Wireless 2012, mobile health